« Previous
Next »
Experimental Hematology
Volume 34, Issue 11
, Pages 1583-1587
, November 2006
Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells
References
- . From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 2000;290:1775–1779
- Multi-organ, multi-lineage engraftment by a single bone marrow–derived stem cell. Cell. 2001;105:369–377
- . In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003;111:843–850
- Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168–1170
- Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6(11):1229–1234
- . Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422:901–904
- G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol. 2005;33:108–119
- Liver from bone marrow in humans. Hepatology. 2000;32:11–16
- Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002;346:738–746
- Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257
- Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization. Haematologica. 2003;88(7):794–800
- Spontaneous splenic rupture following administration of granulocyte-colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of periperal blood stem cells. Biol Blood Marrow Transplant. 1997;3(6):341–343
- Feasibility and safety of G-CSF administration to induce bone marrow–derived cells mobilization in patients with end stage liver disease. J Hepatol. 2006;45:13–19
- Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Liver Int. 2005;26:55–61
- A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470
- Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int. 2004;24:437–445
- Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol. 1999;94(1):169–177
- Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood. 1995;85(9):2482–2489
- Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004;114(3):330–338
- Granulocyte colony-stimulating factor enhances angiogenesis after focal celebral ischemia. Brain Res. 2005;1058:120–128
- Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells. 2005;23(3):347–354
- Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol. 2001;34:683–689
- . Vascular endothelial growth factor and liver regeneration. J Hepatol. 2001;34:759–761
PII: S0301-472X(06)00400-0
doi: 10.1016/j.exphem.2006.06.012
© 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Experimental Hematology
Volume 34, Issue 11
, Pages 1583-1587
, November 2006
